A Telehealth Advance Care Planning Intervention for Older Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-03-25

Study Completion Date

2023-07-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a pilot study to evaluate the usability and feasibility of a telehealth-delivered advance care planning intervention among 20 older patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Telehealth Advance Care Planning Intervention

NCT05875805

Myeloid Malignancy Acute Myeloid Leukemia Myelodysplastic Syndromes +2 more

RECRUITING NA

Feasibility of Telehealth Palliative Care and Digital Symptom Monitoring for Patients With Acute Myeloid Leukemia

NCT04885127

Acute Myeloid Leukemia

COMPLETED NA

Pilot Study of Feasibility of Outpatient Daily High Dose Cytarabine as Consolidation Therapy for Older Patients With Acute Myeloid Leukemia (AML)

NCT02101983

Acute Myeloid Leukemia

COMPLETED NA

A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers

NCT06697600

Oncology Myeloid Leukemia, Acute Cancer

RECRUITING NA

S0112 Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia

NCT00023777

Leukemia

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Older adults with AML and MDS are more likely to receive aggressive care and less likely to utilize hospice at the end-of-life. Advance care planning (ACP) intervention delivered through telehealth may improve patient-reported outcomes and end-of-life care in this population. This pilot study seeks to evaluate the usability and feasibility of a telehealth-delivered advance care planning intervention. We will adapt the Serious Illness Care Program.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Myeloid Leukemia Myelodysplastic Syndromes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patient

The SICG program consists of the Serious Illness Conversation Guide as well as training and system-level support for physicians to conduct ACP conversations.

Group Type EXPERIMENTAL

Telehealth

Intervention Type BEHAVIORAL

Telehealth ACP intervention advance care planning intervention

Control

Intervention Type BEHAVIORAL

For the control arm, no telehealth visit will be scheduled.

Caregiver

The SICG program consists of the Serious Illness Conversation Guide as well as training and system-level support for physicians to conduct ACP conversations.

Group Type EXPERIMENTAL

Telehealth

Intervention Type BEHAVIORAL

Telehealth ACP intervention advance care planning intervention

Control

Intervention Type BEHAVIORAL

For the control arm, no telehealth visit will be scheduled.

Oncology and Palliative Provider

The SICG program consists of the Serious Illness Conversation Guide as well as training and system-level support for physicians to conduct ACP conversations.

Group Type EXPERIMENTAL

Telehealth

Intervention Type BEHAVIORAL

Telehealth ACP intervention advance care planning intervention

Control

Intervention Type BEHAVIORAL

For the control arm, no telehealth visit will be scheduled.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Telehealth

Telehealth ACP intervention advance care planning intervention

Intervention Type BEHAVIORAL

Control

For the control arm, no telehealth visit will be scheduled.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥60 years (conventional definition of older age in AML/MDS)
* AML or MDS diagnosis
* Being managed in the outpatient settings
* Able to provide informed consent
* English-speaking

* Age ≥21 years
* Selected by patient when asked if there is a "family member, partner, friend, or caregiver with whom you discuss or who can be helpful in health-related matters"
* Able to provide informed consent
* English-speaking

Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No